Search Results - "Sharafi, Heidar"

Harm reduction program and hepatitis C prevalence in people who inject drugs (PWID) in Iran: an updated systematic review and cumulative meta-analysis by Rajabi, Abdolhalim, Sharafi, Heidar, Alavian, Seyed Moayed

“…Prevalence of hepatitis C virus (HCV) infection among people who inject drugs (PWID) in Iran is high. Since 2005, the Iranian government has implemented a harm…”
Get full text

Global prevalence of HCV and/or HBV coinfections among people who inject drugs and female sex workers who live with HIV/AIDS: a systematic review and meta-analysis by Rashti, Roya, Alavian, Seyed Moayed, Moradi, Yousef, Sharafi, Heidar, Mohamadi Bolbanabad, Amjad, Roshani, Daem, Moradi, Ghobad

“…Coinfections of hepatitis C virus (HCV) and/or hepatitis B virus (HBV) with human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) are…”
Get full text

Associations Between Buprenorphine\Naloxone and Methadone Treatment and non-Opioid Substance Use in Prescription-Type Opioid Use Disorder: Secondary Analyses From the OPTIMA Study: Associations entre le traitement avec la buprénorphine/naloxone et avec la méthadone et l'utilisation de substances non opioïdes dans le trouble lié à l'usage d'opioïdes de type sur ordonnance : analyses secondaires de l'étude OPTIMA by Bakouni, Hamzah, Sharafi, Heidar, Drouin, Sarah, Fortin, Raphaelle, Marsan, Stéphanie, Brissette, Suzanne, Socias, Maria Eugenia, Le Foll, Bernard, Lim, Ron, Jutras-Aswad, Didier

“…Objectives There is limited evidence on how opioid agonist treatment (OAT) may affect psychoactive non-opioid substance use in prescription-type opioid use…”
Get full text

Treatment of hepatitis C virus infection with direct-acting antiviral agent-based regimens in Iranian patients with hereditary bleeding disorders by Sharafi, Heidar, Behnava, Bita, Azizi-Saraji, Alireza, Namvar, Ali, Anvar, Ali, Salimi, Shima, Alavian, Seyed Moayed

“…Chronic hepatitis C (CHC) is one of the most important comorbidities in patients with hereditary bleeding disorders (HBD). The present study aimed at…”
Get full text

First report on molecular docking analysis and drug resistance substitutions to approved HCV NS5A and NS5B inhibitors amongst Iranian patients by Hasanshahi, Zahra, Hashempour, Ava, Ghasabi, Farzane, Moayedi, Javad, Musavi, Zahra, Dehghani, Behzad, Sharafi, Heidar, Joulaei, Hassan

“…Abstract Background NS5A and NS5B proteins of hepatitis C virus (HCV) are the main targets of compounds that directly inhibit HCV infections. However, the…”
Get full text

Continuum of hepatitis C care cascade in prison and following release in the direct-acting antivirals era by Hariri, Sanam, Sharafi, Heidar, Sheikh, Mahdi, Merat, Shahin, Hashemi, Farnaz, Azimian, Fatemeh, Tamadoni, Babak, Ramazani, Rashid, Gouya, Mohammad Mehdi, Abbasi, Behzad, Tashakorian, Mehrzad, Alasvand, Ramin, Alavian, Seyed Moayed, Poustchi, Hossein, Malekzadeh, Reza

“…People with criminal justice involvement contribute remarkably to the rising hepatitis C virus (HCV) burden; however, the continuum of care is a major barrier…”
Get full text

Economic evaluation of pan-genotypic generic direct-acting antiviral regimens for treatment of chronic hepatitis C in Iran: a cost-effectiveness study by Tasavon Gholamhoseini, Mohammad, Sharafi, Heidar, HL Borba, Helena, Alavian, Seyed Moayed, Sabermahani, Asma, Hajarizadeh, Behzad

“…IntroductionLow-cost generic direct-acting antiviral (DAA) regimens for treatment of hepatitis C virus (HCV) are available in several low-income/middle-income…”
Get full text

Trends in the Prevalence of Hepatitis B Virus, Hepatitis C Virus, and HIV Infections in Iranian Patients with Hereditary Bleeding Disorders by Gharoonpour, Azar, Maleki, Saeideh, Sharifi, Hamid, Osia, Seyedehsara, Sharafi, Heidar, Keshvari, Maryam

“…Patients with hereditary bleeding disorders (HBDs) have always been vulnerable to transfusion-transmitted infections (TTIs) such as hepatitis B virus (HBV),…”
Get full text

Systematic Review and Meta-Analysis of Global Prevalence of HBsAg and HIV and HCV Antibodies among People Who Inject Drugs and Female Sex Workers by Rashti, Roya, Sharafi, Heidar, Alavian, Seyed Moayed, Moradi, Yousef, Mohamadi Bolbanabad, Amjad, Moradi, Ghobad

“…The main objective of this study was to evaluate the prevalence of human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS), hepatitis C…”
Get full text

Injection cessation and relapse to injection and the associated factors among people who inject drugs in Iran: The Rostam study by Mehmandoost, Soheil, Mirzazadeh, Ali, Karamouzian, Mohammad, Khezri, Mehrdad, Sharafi, Heidar, Shahesmaeili, Armita, Maghsoudi, Saiedeh Haji, Ghalekhani, Nima, Tavakoli, Fatemeh, Bazrafshani, Maliheh Sadat, Shokoohi, Mostafa, Aghaali, Niloufar, Haghdoost, Ali Akbar, Sharifi, Hamid

“…Drug injection is a major health-related problem worldwide. Injection cessation and relapse to injection could significantly alter the risk of HIV and…”
Get full text

Prevalence of Naturally-Occurring NS5A and NS5B Resistance-Associated Substitutions in Iranian Patients With Chronic Hepatitis C Infection by Rahimi, Pooneh, Sharafi, Heidar, Bahramali, Golnaz, SajadianFard, FaridehSadat, Asadi, Nafiseh Sadat, Alavian, Seyed Moayed, Iranpur Mobarakeh, Vahid, Moravej, Seyedeh Zahra

“…Hepatitis C virus (HCV), non-structural 5A (NS5A), and non-structural 5B (NS5B) resistance-associated substitutions (RASs) are the main causes of failure to…”
Get full text

Recommendations for the Clinical Management of Hepatitis C in Iran: A Consensus-Based National Guideline by Alavian, Seyed Moayed, Hajarizadeh, Behzad, Bagheri Lankarani, Kamran, Sharafi, Heidar, Ebrahimi Daryani, Nasser, Merat, Shahin, Mohraz, Minoo, Mardani, Masoud, Fattahi, Mohamad Reza, Poustchi, Hossein, Nikbin, Mehri, Nabavi, Mahmood, Adibi, Peyman, Ziaee, Masood, Behnava, Bita, Rezaee-Zavareh, Mohammad Saeid, Colombo, Massimo, Massoumi, Hatef, Bizri, Abdul Rahman, Eghtesad, Bijan, Amiri, Majid, Namvar, Ali, Hesamizadeh, Khashayar, Malekzadeh, Reza

“…Hepatitis C virus (HCV) infection is a major public health issue worldwide, including Iran. The new direct-acting antiviral agents (DAAs) with high efficacy…”
Get full text

Prevalence of Hepatitis B and Hepatitis C Infections among Incarcerated Individuals in Iran: A Cross-Sectional National Bio-behavioral Study in 2019 by Moradi, Ghobad, Alavian, Seyed Moayed, Gholami, Fatemeh, Ramezani, Rashid, Ahangarzadeh, Leila, Moradi, Yousef, Sharafi, Heidar

“…Introduction: To realize the global goals of eliminating hepatitis B virus (HBV) and hepatitis C virus (HCV) by 2030, it is necessary to monitor the status of…”
Get full text

Combination of sofosbuvir, pegylated-interferon and ribavirin for treatment of hepatitis C virus genotype 1 infection: a systematic review and meta-analysis by Dolatimehr, Fardin, Karimi-Sari, Hamidreza, Rezaee-Zavareh, Mohammad Saeid, Alavian, Seyed Moayed, Behnava, Bita, Gholami-Fesharaki, Mohammad, Sharafi, Heidar

“…Background Hepatitis C virus (HCV) infection is an important cause of chronic liver disease which has been affected 3% of world’s population. Some studies have…”
Get full text

Proportion and reasons for loss to follow-up in a cohort study of people who inject drugs to measure HIV and HCV incidence in Kerman, Iran by Mousavian, Ghazal, Ghalekhani, Nima, Tavakoli, Fatemeh, McFarland, Willi, Shahesmaeili, Armita, Sharafi, Heidar, Khezri, Mehrdad, Mehmandoost, Soheil, Zarei, Jasem, Sharifi, Hamid, Mirzazadeh, Ali

“…Understanding the reasons for loss to follow-up (LTFU) in cohort studies, especially among marginalized groups such as people who inject drugs (PWID), is…”
Get full text

Real-life efficacy of generic sofosbuvir/ledipasvir for treatment of Iranian patients with chronic hepatitis C: A cohort study by Sharafi, Heidar, Alavian, Seyed Hoda, Behnava, Bita, Saeid Rezaee-Zavareh, Mohammad, Nikbin, Mehri, Alavian, Seyed Moayed

“…Treatment of hepatitis C virus (HCV) infection with recently introduced direct-acting antiviral agents (DAA) is effective and safe, however there is little…”
Get full text

The Impact of IFNL4 rs12979860 Polymorphism on Spontaneous Clearance of Hepatitis C; A Case-Control Study by Sharafi, Heidar, Alavian, Seyed Moayed, Behnava, Bita, Pouryasin, Ali, Keshvari, Maryam

“…About 30% of individuals with hepatitis C virus (HCV) infection are able to clear HCV spontaneously. Differences in host genetics affect the outcome of HCV…”
Get full text

The interferon lambda 4 rs368234815 predicts treatment response to pegylated-interferon alpha and ribavirin in hemophilic patients with chronic hepatitis C by Keshvari, Maryam, Alavian, Seyed, Behnava, Bita, Pouryasin, Ali, Sharafi, Heidar

“…Background: A dinucleotide variant rs368234815 in interferon lambda 4 (IFNL4) gene was recently found to be associated with the hepatitis C virus (HCV)…”
Get full text

Alanine transaminase as a single marker is not reliable for selecting candidates of pegylated interferon and ribavirin treatment by Sharafi, Heidar, Alavian, Seyed Moayed, Keshvari, Maryam

Get full text

Combination of Ledipasvir and Sofosbuvir for Treatment of Hepatitis C Virus Genotype 1 Infection: Systematic Review and Meta-Analysis by Rezaee-Zavareh, Mohammad Saeid, Hesamizadeh, Khashayar, Behnava, Bita, Alavian, Seyed Moayed, Gholami-Fesharaki, Mohammad, Sharafi, Heidar

“…AbstractBackground and aim. The combination of Sofosbuvir (SOF) and Ledipasvir (LDV) has been lead to considerable enhancement of treatment of hepatitis C…”
Get full text